Clinical Trial Update: Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and efficacy of cannabidiol for grade I/II acute graft-versus-host disease after allogeneic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Rabin Medical Center | Conditions: Graft Versus Host Disease | Phase 1, Phase 2 | Status: UNKNOWN